Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab.

Authors :: Fabre S
Gibert C
Lechiche C
Jorgensen C
Sany J
Source :: The Journal of rheumatology [J Rheumatol] 2005 Dec; Vol. 32 (12), pp. 2432-3.
Publication Year :: 2005
Abstract: Anti-tumor necrosis factor-a (anti-TNF-a) therapy strategies result in significant clinical benefits in patients with rheumatoid arthritis, but with an increased rate of serious infectious diseases. We describe a patient receiving infliximab who developed a primary cutaneous Nocardia otitidiscaviarum infection after a skin injury.

Subjects :: Aged
Antibodies, Monoclonal therapeutic use
Antirheumatic Agents therapeutic use
Arthritis, Rheumatoid complications
Diabetes Mellitus, Type 1 complications
Humans
Infliximab
Male
Nocardia Infections pathology
Skin injuries
Skin Diseases, Bacterial pathology
Tumor Necrosis Factor-alpha antagonists & inhibitors
Wounds and Injuries microbiology
Antibodies, Monoclonal adverse effects
Antirheumatic Agents adverse effects
Arthritis, Rheumatoid drug therapy
Nocardia Infections chemically induced
Skin Diseases, Bacterial chemically induced

Tools